Transform the efficiency and reliability of your research with Beckman Coulter automated lab protocols. Discover protocol information and insights relevant to your application here.
Dendritic cells (DCs) have long been recognized as the most potent antigen-producing cells with the capacity to initiate naive T cell response in vitro and in vivo. During their differentiation and maturation pathways, dendritic cells can efficiently capture, process and present antigens for T cell activation making DCs an attractive choice for cancer vaccines.
Tools, technologies, antibodies and detection methods from Beckman Coulter are helping researchers take a more holistic approach to understanding the immune response and how it plays out in pathogenic disease.